Cited by 168Ethics in Clinical ResearchEthics and bioethics in healthcareBiomedical Ethics and Regulation

Active choice but not too active: Public perspectives on biobank consent models

Open access
Simon, Christian M., L’Heureux, Jamie, Murray, Jeffrey C., Winokur, Patricia, Weiner, George, Newbury, Elizabeth, Shinkunas, Laura, Zimmerman, Bridget·2011·Genetics in Medicine

Abstract

Purpose Despite important recent work, US public attitudes toward specific biobank consent models are not well understood. Public opinion data can help shape efforts to develop ethically sound and publicly trusted mechanisms for informing and consenting prospective biobank donors. The purpose of this study was to explore public perspectives toward a range of consent models currently being used or considered for use among comprehensive US biobanks. Methods The study used an exploratory mixed-methods design, using focus groups and telephone surveys. Eligible participants were English-speaking residents in the catchment area of a comprehensive biobank being developed at the University of Iowa. Results Forty-eight participants in seven focus groups and 751 survey participants were recruited. Biobanks were unfamiliar to almost all study participants but were seen as valuable resources. Most focus group (63%) and survey (67%) participants preferred a prospective opt-in over an opt-out consent approach. Broad, research-unspecific consent was preferred over categorical and study-specific consent models for purposes of approving future research use. Conclusion Many individuals may want to make an active and informed choice at the point of being approached for biobank participation but are prepared to consent broadly to future research use and to forego additional choices as a result.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/gim.0b013e31821d2f88

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the Simon et al. study, broad consent was the most commonly preferred scope (54% of focus group participants and 41% of survey participants), study-specific consent was preferred by 21% and 29%, and categorical consent by 21% and 25%.

    “In terms of scope, broad consent was the most commonly preferred (54% of focus group participants and 41% of survey participants), for reasons such as greater ease and flexibility for research (and thus a boost to research output) and recognized uncertainties regarding future research. Study-specific consent was preferred by 21% and 29% of focus group and survey participants, respectively, and”

    From Lessons from HeLa Cells: The Ethics and Policy of Biospecimens (2016) · cites this paper as [128]

    The Results (Survey results, page unavailable) give the claimed survey preferences: 41% broad, 29% study-specific, and 25% categorical. The Results (Focus group results, page unavailable) say broad consent received the strongest support and describe participants’ reasons, including research flexibility and uncertainty about future studies. Our copy does not give the claimed separate focus-group percentages of 54%, 21%, and 21%; the Discussion reports only that 42% preferred categorical or study-specific consent combined. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In support of proposed regulatory changes, the NPRM cited four articles reporting public opinions about biospecimen research, but these publications do not necessarily suggest consensus.

    “In support of proposed regulatory changes, the NPRM cited four articles reporting public opinions about biospecimen research (77, 128, 140, 144). But as summarized below, these publications do not necessarily suggest consensus.”
  • In the Simon et al. study, if study-specific and categorical consent preferences are combined as a general control/choice model, it could be seen as preferred (by 42% of focus group and 54% of survey participants) over broad consent.

    “The authors noted that, theoretically, the proportions that preferred study-specific and categorical consent could be combined on the grounds that both models promote control and choice over future use. If so, a general control/choice model could be seen as preferred (by 42% and 54% of focus group and survey participants, respectively) over broad consent.”
  • In the Simon et al. study, a majority (63% of focus group participants and 67% of survey participants) preferred an opt-in approach to initial consent, while opt-out was preferred by 25% and 18%, respectively, and "no consent" was preferred by 5% of survey respondents.

    “A majority (63% of focus group participants and 67% of survey participants) preferred an opt-in approach to initial consent. Common reasons included that opt-in provided the opportunity to make a more positive, active, and informed choice and would receive greater public acceptance as fitting with traditional notions of consent. Opt-out was preferred by 25% and 18% of focus group and survey”
  • In the Simon et al. telephone survey, an opt-out approach to initial consent was the preferred choice for only 18%, but it was supported by 78%.

    “An opt-out approach to initial consent was the preferred choice for only 18%, but it was supported by 78%.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 34 · Cited by 168

Research works printed but not linked: 33

  1. [1]Watson PH Wilson-McManus JE Barnes RO Evolutionary concepts in biobanking—the BC BioLibrary J Transl Med 2009 7 95 19909513 PMC2785772
  2. [4]Hoeyer K Donors perceptions of consent to and feedback from biobank research: time to acknowledge diversity? Public Health Genomics 2010 13 345 352 19940458
  3. [5]Elger BS Caplan AL Consent and anonymization in research involving biobanks: differing terms and norms present serious barriers to an international framework EMBO Rep 2006 7 661 666 16819458 PMC1500833
  4. [8]Rothwell E Anderson R Botkin J Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research Policy Polit Nurs Pract 2010 11 5 12 20457727 PMC5847286
  5. [9]Koontz JI Haithcock D Cumbea V Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository Am Heart J 2009 158 719 725 19853688
  6. [10]Goldenberg AJ Hull SC Botkin JR Wilfond BS Pediatric biobanks: approaching informed consent for continuing research after children grow up J Pediatr 2009 155 578 583 19595370 PMC4779602
  7. [11]Pulley J Clayton E Bernard GR Roden DM Masys DR Principles of human subjects protections applied in an opt-out, de-identified biobank Clin Transl Sci 2010 3 42 48 20443953 PMC3075971
  8. [12]Roden DM Pulley JM Basford MA Development of a large-scale de-identified DNA biobank to enable personalized medicine Clin Pharmacol Ther 2008 84 362 369 18500243 PMC3763939
  9. [14]Junghans C Feder G Hemingway H Timmis A Jones M Recruiting patients to medical research: double blind randomised trial of “opt-in” versus “opt-out” strategies BMJ 2005 331 940 16157604 PMC1261191
  10. [15]Rogers CG Tyson JE Kennedy KA Broyles RS Hickman JF Conventional consent with opting in versus simplified consent with opting out: an exploratory trial for studies that do not increase patient risk J Pediatr 1998 132 606 611 9580757
  11. [16]Simon CM Kodish ED Step into my zapatos, doc: understanding and reducing communication disparities in the multicultural informed consent setting Perspect Biol Med 2005 48 suppl 1 S123 S138 15842091
  12. [17]Sachs GA Hougham GW Sugarman J Conducting empirical research on informed consent: challenges and questions IRB 2003 suppl 25 S4 S10 14870730
  13. [18]Murphy J Scott J Kaufman D Geller G LeRoy L Hudson K Public perspectives on informed consent for biobanking Am J Public Health 2009 99 2128 2134 19833988 PMC2775766
  14. [19]Winickoff DE Winickoff RN The charitable trust as a model for genomic biobanks N Engl J Med 2003 349 1180 1184 13679534
  15. [20]Caulfield T McGuire AL Cho M Research ethics recommendations for whole-genome research: consensus statement PLoS Biol 2008 6 e73 18366258 PMC2270329
  16. [21]Deschenes M Cardinal G Knoppers BM Glass KC Human genetic research, DNA banking and consent: a question of ‘form’? Clin Genet 2001 59 221 239 11298677
  17. [24]Hansson MG Dillner J Bartram CR Carlson JA Helgesson G Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 2006 7 266 269 16510336
  18. [29]Haga SB Beskow LM Ethical, legal, and social implications of biobanks for genetics research Adv Genet 2008 60 505 544 18358331
  19. [30]McGuire AL Hamilton JA Lunstroth R McCullough LB Goldman A DNA data sharing: research participants’ perspectives Genet Med 2008 10 46 53 18197056 PMC2767246
  20. [31]Cambon-Thomsen A Rial-Sebbag E Knoppers BM Trends in ethical and legal frameworks for the use of human biobanks Eur Respir J 2007 30 373 382 17666560
  21. [32]Secko DM Preto N Niemeyer S Burgess MM Informed consent in biobank research: a deliberative approach to the debate Soc Sci Med 2009 68 781 789 19095337
  22. [33]Ludman EJ Fullerton SM Spangler L Glad you asked: participants’ opinions of re-consent for dbGap data submission J Empir Res Hum Res Ethics 2010 5 9 16 20831417 PMC3071850
  23. [34]Lemke AA Wolf WA Hebert-Beirne J Smith ME Public and biobank participant attitudes toward genetic research participation and data sharing Public Health Genomics 2010 13 368 377 20805700 PMC2951726
  24. [35]Willison DJ Swinton M Schwartz L Alternatives to project-specific consent for access to personal information for health research: insights from a public dialogue BMC Med Ethics 2008 9 18 19019239 PMC2601042
  25. [36]Tupasela A Sihvo S Snell K Jallinoja P Aro AR Hemminki E Attitudes towards biomedical use of tissue sample collections, consent, and biobanks among Finns Scand J Public Health 2010 38 46 52 19906772
  26. [37]McCarty CA Wilke RA Giampietro PF Westbrook SD Caldwell MD Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank Personalized Med 2005 2 49 79 29793241
  27. [38]Kitzinger J Qualitative research. Introducing focus groups BMJ 1995 311 299 302 7633241 PMC2550365
  28. [39]Krueger RA Focus groups: a practical guide for applied research 2 Thousand Oaks, CA Sage Publications 1994
  29. [42]Allen J McNamara B Reconsidering the value of consent in biobank research Bioethics 2011 25 155 166 19659851
  30. [43]Vermeulen E Schmidt MK Aaronson NK A trial of consent procedures for future research with clinically derived biological samples Br J Cancer 2009 101 1505 1512 19861997 PMC2778511
  31. [44]Beskow LM Burke W Merz JF Informed consent for population-based research involving genetics JAMA 2001 286 2315 2321 11710898
  32. [45]Beskow LM Linney KN Radtke RA Heinzen EL Goldstein DB Ethical challenges in genotype-driven research recruitment Genome Res 2010 20 705 709 20418491 PMC2877567
  33. [46]Fleming JM Biobanks: professional, donor and public perceptions of tissue banks and the ethical and legal challenges of consent, linkage and the disclosure of research results PhD thesis Institute for Molecular Science, The University of Queensland 2007

Authors
Simon, C. M., L’Heureux, J., Murray, J. C., Winokur, P., Weiner, G., Newbury, E., Shinkunas, L., & Zimmerman, B.
Affiliations
University of Iowa (US)
Corresponding author
Simon, Christian M.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2011-09
Volume
13
Issue
9
Pages
821-831
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2115300617
Cited by
168
References
34
Citations by year
2026: 4 · 2025: 3 · 2024: 7 · 2023: 5 · 2022: 6 · 2021: 26 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 15 · 2016: 6 · 2015: 17 · 2014: 11 · 2013: 17 · 2012: 19
FWCI
16.04
Type
journal article
Language
en
Open access
Locations
  • Genetics in Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Institute of Clinical and Translational Sciences
  • University of Northern Iowa
  • National Institutes of Health (UL1TR000442)
  • Roy J. and Lucille A. Carver College of Medicine, University of Iowa
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
  • Health Sciences › Medicine › Physiology › Biomedical Ethics and Regulation
Keywords
biobanks, informed consent, consent models, public attitudes, opt-in consent, presumed consent, broad consent, research utilization, informed choice, public trust
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Informed Consent, Male, Middle Aged, Public Opinion, United States, Mental Competency, Focus Groups, Biological Specimen Banks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review